Scientific Sessions 2024  /  Systemic Inflammation: Evaluating Potential New Targets in the Management of Chronic ASCVD and CKD  /  Systemic inflammation: Evaluating a potential new target in the treatment of ASCVD and CKD
Logo

American Heart Association

  131
  0

Final ID:

Systemic inflammation: Evaluating a potential new target in the treatment of ASCVD and CKD

  • Ridker, Paul  ( , Boston , Massachusetts , United States )
  • Weber, Brittany  ( BRIGHAM AND WOMENS HOSPITAL , Boston , Massachusetts , United States )
  • Shah, Binita  ( NEW YORK UNIVERSITY , New York , New York , United States )
    • Author Disclosures:
    Paul Ridker: No Answer | Brittany Weber: DO have relevant financial relationships ; Advisor:Novo Nordisk:Active (exists now) ; Advisor:Aegpha:Past (completed) ; Advisor:BMS:Past (completed) ; Advisor:Kiniksa:Active (exists now) ; Advisor:Horizon Therapeutics:Past (completed) | Binita Shah: DO have relevant financial relationships ; Researcher:Novo Nordisk:Active (exists now) ; Advisor:Philips Volcano:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Systemic Inflammation: Evaluating Potential New Targets in the Management of Chronic ASCVD and CKD

Sunday, 11/17/2024 , 03:15PM - 04:00PM

Learning Studio

More abstracts from these authors:
Breaking the Cycle: Addressing Residual Inflammatory Risk in ASCVD & CKD with Next-Generation Targeted

Everett Brendan, Ridker Paul, Shah Binita

Discussion: Next Directions in Interventional Science

Shah Binita

You have to be authorized to contact abstract author. Please, Login
Not Available